4.8 Review

Senescent cells and osteoarthritis: a painful connection

期刊

JOURNAL OF CLINICAL INVESTIGATION
卷 128, 期 4, 页码 1229-1237

出版社

AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI95147

关键词

-

资金

  1. Unity Biotechnology
  2. Morton Goldberg Chair
  3. Bloombergsimilar toKimmel Institute for Cancer Immunotherapy
  4. NIH [AG009909]
  5. Office of the Assistant Secretary of Defense for Health Affairs through the Peer Reviewed Medical Research Program [W81XWH-17-1-0627]
  6. NATIONAL INSTITUTE ON AGING [R37AG009909, R56AG009909] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Senescent cells (SnCs) are associated with age-related pathologies. Osteoarthritis is a chronic disease characterized by pain, loss of cartilage, and joint inflammation, and its incidence increases with age. For years, the presence of SnCs in cartilage isolated from patients undergoing total knee artificial implants has been noted, but these cells' relevance to disease was unclear. In this Review, we summarize current knowledge of SnCs in the multiple tissues that constitute the articular joint. New evidence for the causative role of SnCs in the development of posttraumatic and age-related arthritis is reviewed along with the therapeutic benefit of SnC clearance. As part of their senescence-associated secretory phenotype, SnCs secrete cytokines that impact the immune system and its response to joint tissue trauma. We present concepts of the immune response to tissue trauma as well as the interactions with SnCs and the local tissue environment. Finally, we discuss therapeutic implications of targeting SnCs in treating osteoarthritis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据